Hensoldt's Order Book Tells One Story — Its Cash Flow Tells Another
Published on 08/11/2026 at 18:32 | Redaktion boerse-global.de
The defense electronics group finds itself in an unusual position: record demand, a doubling of order intake, and a stock that analysts increasingly view as priced for perfection. Hensoldt's first-half results for 2026 lay bare the tension between a booming pipeline and the financial strain of scaling up to meet it.
Revenue for the period climbed 23.6 percent to 1.167 billion euros, with second-quarter sales alone up 22 percent year-on-year to 671 million euros. Adjusted EBITDA margin ticked up from 11.3 to 11.8 percent — progress, though still thin for a company growing at this clip. The headline number, however, is the order intake: 2.8 billion euros in the first six months, double the prior-year figure, powered by a second quarter that saw orders surge 89 percent to 1.33 billion euros.
That intake has pushed the backlog to a record 10.4 billion euros, giving management visibility that most industrial peers would envy. The company reaffirmed its full-year guidance of roughly 2.75 billion euros in revenue, a book-to-bill ratio between 1.5 and 2.0, and an adjusted EBITDA margin of 18.5 to 19.0 percent.
The Cost of Building for a Boom
The gap between those targets and current margins reflects a deliberate strategy — and a hefty price tag. Hensoldt posted an adjusted free cash flow of minus 136 million euros for the half, an improvement from the minus 181 million euros recorded a year earlier but still firmly in negative territory. Rival RENK, by contrast, generated positive cash flow over the same stretch, a comparison that has not been lost on investors increasingly focused on balance-sheet resilience.
The cash burn stems from an aggressive expansion program. Hensoldt plans roughly 1,600 new hires by the end of 2026, a headcount increase of more than 16 percent. It is also building a "software-defined defence" development center in Leinfelden-Echterdingen near Stuttgart alongside Bosch, a joint venture expected to create around 300 jobs by the end of 2027. These are upfront costs for a multi-year European defense build-up that management clearly believes is structural rather than cyclical.
Scaling up operations at this pace brings its own risks — and not just financial ones. As your team grows and your facilities expand, keeping on top of workplace safety obligations becomes more complex. A free toolkit with 41 ready-to-use templates and checklists helps you document risks properly and stay compliant as your business evolves. Download the free Risk Assessment Toolkit
The completed acquisition of Dutch optronics specialist Nedinsco, which has now cleared all regulatory hurdles, fits the same consolidation logic — extending Hensoldt's reach along the value chain at a moment when capacity is at a premium.
A Stock That Has Run Ahead of the Fundamentals
The market has already embraced much of this narrative. The shares have gained 23.38 percent since the start of the year and 23.58 percent over the past 30 days. On Tuesday, the stock traded at 90.56 euros, down 1.09 percent on the day — a modest pullback after the recent run. The gap to the 52-week high of 117.70 euros, reached in October last year, stands at 23.06 percent.
That disconnect between momentum and valuation has split the analyst community. Jefferies downgraded the stock from "Buy" to "Hold" on Thursday while simultaneously raising its price target from 94 to 98 euros, arguing that the valuation now looks rich relative to the broader European defense sector despite solid fundamentals. JPMorgan, also weighing in on Thursday, kept its "Neutral" rating but lifted its target more aggressively from 85 to 100 euros. Both houses acknowledge the operational strength — neither is willing to chase the stock further.
The most bearish voice comes from mwb research, which maintains a "Sell" recommendation with a price target of just 62 euros — implying roughly a third of downside from current levels. The stock's technical position adds to the caution: the relative strength index sits at 69.6, just shy of the 70 threshold that chartists consider overbought, while the share price trades 18.34 percent above its 50-day moving average. With annualized volatility around 49 percent, this remains a high-octane holding by any measure.
Insiders and Institutions Bet Differently
Against that skeptical backdrop, some notable buyers have emerged. BlackRock disclosed a 4.96 percent voting stake in mid-July, triggered by a threshold crossing at subsidiary level — and, separately, raised its holding to 4.91 percent as of August 5, news that emerged on August 11. The stock gained 4.29 percent in the week following that disclosure.
Management has also put money where its mouth is. CEO Oliver Dörre and board member Inka Tews both purchased shares in late June, as documented in mandatory insider-trading filings. Institutional and insider confidence are converging at a moment when the analyst community is turning more cautious — a classic sign of a market debating whether the story has already been told.
When management and major institutions are backing a growth story, it pays to have your own house in order — including the health and safety documentation regulators expect. More than 37,000 UK businesses already use this free toolkit with 41 checklists and templates to stay compliant and protect their teams. Get the free Health & Safety Toolkit
Regulatory Shifts and the Path Ahead
The order landscape remains fluid. The cancellation of the F126 frigate program, valued at around 200 million euros, is expected to have only minor financial consequences, according to the company. Meanwhile, management sees potential in a second tranche of the MEKO 200 frigate class — a reminder of how quickly opportunities can emerge in this sector.
The central question for investors remains whether the structural defense cycle can justify the current valuation, or whether the share price has already sprinted ahead of what the numbers can support. With a market capitalization of 10.48 billion euros, the stock is pricing in a substantial margin expansion over the coming quarters. The order book provides the raw material for that growth — but converting a record backlog into positive cash flow is the test that will ultimately decide whether the rally has further to run.
